Los Angeles Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $72.2M | Buy |
|
|||||
|
2025
Q2 | $15.3M | Buy |
|
|||||
|
2025
Q1 | $9.97M | Buy |
|
|||||
|
2024
Q4 | $2.53M | Buy |
|
|||||
|
2024
Q3 | $710K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $666K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $5.39M | Sell |
|
|||||
|
2023
Q1 | $7.36M | Sell |
|
|||||
|
2022
Q4 | $7.96M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $1.67M | Buy |
|
|||||
|
2020
Q1 | $927K | Sell |
|
|||||
|
2019
Q4 | $1.26M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $1.13M | Sell |
|
|||||
|
2018
Q4 | $1.15M | Sell |
|
|||||
|
2018
Q3 | $2.99M | Buy |
|
|||||
|
2018
Q2 | $1.63M | Buy |
|
|||||
|
2018
Q1 | $424K | Sell |
|
|||||
|
2017
Q4 | $660K | Sell |
|
|||||
|
2017
Q3 | $6.84M | Buy |
|
|||||
|
2017
Q2 | $3.02M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $2.86M | Sell |
|
|||||
|
2016
Q3 | $10.5M | Buy |
|
|||||
|
2016
Q2 | $244K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $2.13M | Buy |
|
|||||
|
2015
Q2 | $2.56M | Sell |
|
|||||
|
2015
Q1 | $12.1M | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $1.8M | Sell |
|
|||||
|
2013
Q4 | $3.5M | Sell |
|
|||||
|
2013
Q3 | $10.1M | Buy |
|
|||||
|
2013
Q2 | $6.65M | Buy |
|